Jesse Goodman is a professor in the School of Medicine and director of Georgetown Center on Medical Product Access, Safety and Stewardship (COMPASS). He specializes in the Division of Infectious Diseases and Travel Medicine.
International activities include:
- Previously served as director of FDA’s Center for Biologics Evaluation and Research (CBER), which oversees activities critical to U.S. and global preparedness and the development, evaluation, safety, quality, and availability of blood, vaccines, gene and cell therapies, and other biologics.
- Initiated and co-chaired the United States Task Force on Antimicrobial Resistance, which produced the nation’s first Public Health Action Plan to Combat Antimicrobial Resistance.
- Led the 2009 H1N1 pandemic response and the medical countermeasure review for FDA.